Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 13.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 1999 to 2008

Recipients with Heart-Lung Transplants

  Year of Transplant
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Functioning Graft at Discharge 34 33 21 22 17 35 29 24 29 21
With Immunosuppression Info 33 33 21 22 17 35 29 24 28 20
Corticosteroids Any in Category 100.0% 100.0% 100.0% 100.0% 94.1% 100.0% 100.0% 100.0% 100.0% 100.0%
Steroids 100.0% 100.0% 100.0% 100.0% 94.1% 100.0% 100.0% 100.0% 100.0% 100.0%
Cyclosporine Any in Category 66.7% 81.8% 71.4% 59.1% 47.1% 37.1% 48.3% 29.2% 3.6% 10.0%
Cyclosporin 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 5.0%
Sandimmmune 18.2% 6.1% 9.5% 13.6% 5.9% 0.0% 0.0% 0.0% 0.0% 0.0%
Neoral 48.5% 72.7% 57.1% 40.9% 23.5% 22.9% 31.0% 12.5% 3.6% 5.0%
Gengraf 0.0% 3.0% 4.8% 4.5% 17.6% 14.3% 13.8% 16.7% 0.0% 0.0%
Eon 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 3.4% 0.0% 0.0% 0.0%
Tacrolimus Any in Category 39.4% 27.3% 23.8% 45.5% 52.9% 65.7% 55.2% 75.0% 96.4% 90.0%
Tacrolimus 39.4% 27.3% 23.8% 45.5% 52.9% 65.7% 55.2% 75.0% 96.4% 90.0%
Antimetabolites Any in Category 84.8% 93.9% 95.2% 95.5% 82.4% 82.9% 96.6% 91.7% 85.7% 95.0%
Mycophenolate Mofetil 48.5% 45.5% 52.4% 40.9% 29.4% 54.3% 55.2% 70.8% 67.9% 85.0%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 3.6% 5.0%
Azathioprine 36.4% 48.5% 42.9% 54.5% 52.9% 28.6% 41.4% 20.8% 14.3% 5.0%
mTOR Inhibitors Any in Category 0.0% 0.0% 0.0% 0.0% 5.9% 2.9% 0.0% 0.0% 0.0% 0.0%
Sirolimus 0.0% 0.0% 0.0% 0.0% 5.9% 2.9% 0.0% 0.0% 0.0% 0.0%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of May 4, 2009.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.



PDF FormatRequires Adobe Acrobat Reader